1 Patent
- US117332432023Use of Acamprosate to Modulate ERK1/2 Activation in Animal Models for FXS and ASD and Individuals Diagnosed with FXS and ASD
Indiana University Research And Technology Corporation
0 cites
Indiana University Research And Technology Corporation